These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21769110)

  • 1. Matrix metalloproteinase-9 polymorphisms affect plasma MMP-9 levels and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
    Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
    Pharmacogenomics J; 2012 Dec; 12(6):489-98. PubMed ID: 21769110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of matrix metalloproteinase (MMP)-2 polymorphisms on responsiveness to antihypertensive therapy of women with hypertensive disorders of pregnancy.
    Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Lacchini R; Duarte G; Tanus-Santos JE
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):262-7. PubMed ID: 22672240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy.
    Palei AC; Sandrim VC; Amaral LM; Machado JS; Cavalli RC; Duarte G; Tanus-Santos JE
    Exp Mol Pathol; 2012 Apr; 92(2):217-21. PubMed ID: 22327101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitor of matrix metalloproteinase-1 polymorphism, plasma TIMP-1 levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
    Luizon MR; Palei AC; Sandrim VC; Amaral LM; Machado JS; Lacchini R; Cavalli RC; Duarte G; Tanus-Santos JE
    Pharmacogenomics J; 2014 Dec; 14(6):535-41. PubMed ID: 24913092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase (MMP)-9 genotypes and haplotypes in preeclampsia and gestational hypertension.
    Palei AC; Sandrim VC; Duarte G; Cavalli RC; Gerlach RF; Tanus-Santos JE
    Clin Chim Acta; 2010 Jun; 411(11-12):874-7. PubMed ID: 20211160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. eNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertension.
    Sandrim VC; Palei AC; Luizon MR; Izidoro-Toledo TC; Cavalli RC; Tanus-Santos JE
    Pharmacogenomics J; 2010 Feb; 10(1):40-5. PubMed ID: 19704415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy.
    Luizon MR; Palei ACT; Belo VA; Amaral LM; Lacchini R; Duarte G; Cavalli RC; Sandrim VC; Tanus-Santos JE
    Pharmacogenomics J; 2017 Oct; 17(5):427-434. PubMed ID: 27168100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children.
    Belo VA; Souza-Costa DC; Luizon MR; Lanna CM; Carneiro PC; Izidoro-Toledo TC; Ferraz KC; Tanus-Santos JE
    Int J Obes (Lond); 2012 Jan; 36(1):69-75. PubMed ID: 21844877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional matrix metalloproteinase (MMP)-9 genetic variants modify the effects of hemodialysis on circulating MMP-9 levels.
    Marson BP; Lacchini R; Belo V; Mattos SG; da Costa BP; Poli-de-Figueiredo CE; Tanus-Santos JE
    Clin Chim Acta; 2012 Dec; 414():46-51. PubMed ID: 23010359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension.
    Tayebjee MH; Karalis I; Nadar SK; Beevers DG; MacFadyen RJ; Lip GY
    Am J Hypertens; 2005 Mar; 18(3):325-9. PubMed ID: 15797648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine.
    Martins-Oliveira A; Gonçalves FM; Speciali JG; Fontana V; Izidoro-Toledo TC; Belo VA; Dach F; Tanus-Santos JE
    J Neuroimmunol; 2012 Nov; 252(1-2):89-94. PubMed ID: 22907074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal iNOS genetic polymorphisms and hypertensive disorders of pregnancy.
    Amaral LM; Palei AC; Sandrim VC; Luizon MR; Cavalli RC; Duarte G; Tanus-Santos JE
    J Hum Hypertens; 2012 Sep; 26(9):547-52. PubMed ID: 21716319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension.
    Sandrim VC; Palei AC; Cavalli RC; Araújo FM; Ramos ES; Duarte G; Tanus-Santos JE
    Mol Hum Reprod; 2009 Feb; 15(2):115-20. PubMed ID: 19060000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A functional matrix metalloproteinase (MMP)-9 polymorphism modifies plasma MMP-9 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Passos CJ; Gerlach RF; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2010 Sep; 408(19):4085-92. PubMed ID: 20554312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic polymorphism of matrix metalloproteinase 9 (MMP-9) affects the changes in circulating MMP-9 levels induced by highly active antiretroviral therapy in HIV patients.
    Demacq C; Vasconcellos VB; Marcaccini AM; Gerlach RF; Machado AA; Tanus-Santos JE
    Pharmacogenomics J; 2009 Aug; 9(4):265-73. PubMed ID: 19381161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy.
    Luizon MR; Sandrim VC; Palei AC; Lacchini R; Cavalli RC; Duarte G; Tanus-Santos JE
    Hypertens Res; 2012 Sep; 35(9):917-21. PubMed ID: 22573202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of trophoblast invasion related genes mRNA and protein in human placenta in preeclampsia].
    Zhang H; Lin QD; Qiao C
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):509-13. PubMed ID: 17083831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
    Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
    Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.
    Luizon MR; Belo VA; Palei AC; Amaral LM; Lacchini R; Sandrim VC; Duarte G; Cavalli RC; Tanus-Santos JE
    Hypertens Res; 2015 May; 38(5):361-6. PubMed ID: 25716650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases 1 and 2 as potential biomarkers for gestational hypertension.
    Ab Hamid J; Mohtarrudin N; Osman M; Andi Asri AA; Wan Hassan WH; Aziz R
    Singapore Med J; 2012 Oct; 53(10):681-3. PubMed ID: 23112021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.